149 related articles for article (PubMed ID: 38654216)
1. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
[TBL] [Abstract][Full Text] [Related]
2. Embryonic Stem Cells Modulate the Cancer-Permissive Microenvironment of Human Uveal Melanoma.
Liu J; Huang Z; Yang L; Wang X; Wang S; Li C; Liu Y; Cheng Y; Wang B; Sang X; He X; Wang C; Liu T; Liu C; Jin L; Liu C; Zhang X; Wang L; Wang Z
Theranostics; 2019; 9(16):4764-4778. PubMed ID: 31367256
[TBL] [Abstract][Full Text] [Related]
3. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
Zhan Z; Lin K; Wang T
BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
[TBL] [Abstract][Full Text] [Related]
4. Multi-Platform Omics Analysis for Identification of Molecular Characteristics and Therapeutic Targets of Uveal Melanoma.
Kim YJ; Park SJ; Maeng KJ; Lee SC; Lee CS
Sci Rep; 2019 Dec; 9(1):19235. PubMed ID: 31848373
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma.
Xu Y; Han W; Xu WH; Wang Y; Yang XL; Nie HL; Yao J; Shen GL; Zhang XF
J Cell Biochem; 2019 Nov; 120(11):19202-19214. PubMed ID: 31270856
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and Functional Analysis of
Mei S; Li Y; Kang X
Dis Markers; 2022; 2022():4143447. PubMed ID: 35432628
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma.
Chen Y; Zheng A; Zhang Y; Xiao M; Zhao Y; Wu X; Li M; Du F; Chen Y; Chen M; Li W; Li X; Sun Y; Gu L; Xiao Z; Shen J
Front Immunol; 2022; 13():1026076. PubMed ID: 36311731
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair.
Wang XC; Yue X; Zhang RX; Liu TY; Pan ZZ; Yang MJ; Lu ZH; Wang ZY; Peng JH; Le LY; Wang GY; Peng QH; Meng Y; Huang W; Liu RY
Clin Cancer Res; 2019 Jul; 25(14):4567-4579. PubMed ID: 30979744
[TBL] [Abstract][Full Text] [Related]
9. Cross talk between tumor stemness and microenvironment for prognosis and immunotherapy of uveal melanoma.
Wan Q; Ren X; Tang J; Ma K; Deng YP
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11951-11968. PubMed ID: 37420017
[TBL] [Abstract][Full Text] [Related]
10. Repression of genes involved in melanocyte differentiation in uveal melanoma.
Bergeron MA; Champagne S; Gaudreault M; Deschambeault A; Landreville S
Mol Vis; 2012; 18():1813-22. PubMed ID: 22815634
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells.
Zhang W; Wu H; Yang M; Ye S; Li L; Zhang H; Hu J; Wang X; Xu J; Liang A
Oncotarget; 2016 Mar; 7(12):13538-50. PubMed ID: 26646449
[TBL] [Abstract][Full Text] [Related]
12. Embryonic stem cell microenvironment suppresses the malignancy of cutaneous melanoma cells by down-regulating PI3K/AKT pathway.
Wang C; Wang X; Liu J; Huang Z; Li C; Liu Y; Sang X; Yang L; Wang S; Su Y; Liu C; Liu Y; Wang Z
Cancer Med; 2019 Aug; 8(9):4265-4277. PubMed ID: 31173492
[TBL] [Abstract][Full Text] [Related]
13. RASD2 promotes the development and metastasis of uveal melanoma via enhancing glycolysis.
Xie M; Xin C
Biochem Biophys Res Commun; 2022 Jun; 610():92-98. PubMed ID: 35461072
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification.
Lei P; Xue L; Wu Y; Zhong J
Bioengineered; 2022; 13(7-12):15033-15044. PubMed ID: 37105900
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
Wang W; Zhao H; Wang S
Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.
Zhao M; Yu Y; Song Z
Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma.
Jin W; Wu L; Hu L; Fu Y; Fan Z; Mou Y; Ma K
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16691-16703. PubMed ID: 37725244
[TBL] [Abstract][Full Text] [Related]
18. BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma.
Herbert K; Binet R; Lambert JP; Louphrasitthiphol P; Kalkavan H; Sesma-Sanz L; Robles-Espinoza CD; Sarkar S; Suer E; Andrews S; Chauhan J; Roberts ND; Middleton MR; Gingras AC; Masson JY; Larue L; Falletta P; Goding CR
Genes Dev; 2019 Mar; 33(5-6):310-332. PubMed ID: 30804224
[TBL] [Abstract][Full Text] [Related]
19. Ku70 suppresses alternative end joining in G1-arrested progenitor B cells.
Liang Z; Kumar V; Le Bouteiller M; Zurita J; Kenrick J; Lin SG; Lou J; Hu J; Ye AY; Boboila C; Alt FW; Frock RL
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006647
[TBL] [Abstract][Full Text] [Related]
20. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma.
Wang T; Zhang Y; Bai J; Xue Y; Peng Q
BMC Cancer; 2021 Sep; 21(1):1068. PubMed ID: 34587931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]